Article Information
vol. 7 no. 1
Published By
Online ISSN
History
- Received November 2, 2020
- Accepted November 5, 2020
- Published online February 22, 2021.
Article Versions
- previous version (December 17, 2020 - 09:28).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright ©ERS 2021 This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
Author Information
- David M.G. Halpin1⇑,
- Claus F. Vogelmeier2,
- Karen Mezzi3,
- Pritam Gupta4,
- Konstantinos Kostikas5 and
- Jadwiga A. Wedzicha6
- 1University of Exeter Medical School, College of Medicine and Health, University of Exeter, Exeter, UK
- 2University Medical Centre Giessen and Marburg, member of the German Centre for Lung Research (DZL), Marburg, Germany
- 3Novartis Pharma AG, Basel, Switzerland
- 4Novartis Healthcare Pvt. Ltd., Hyderabad, India
- 5Respiratory Medicine Dept, University of Ioannina, Ioannina, Greece
- 6National Heart and Lung Institute, Imperial College London, London, UK
- David M.G. Halpin, University of Exeter Medical School, College of Medicine and Health, University of Exeter, Exeter, UK. E-mail: d.halpin{at}nhs.net
Funding
Novartis Pharma AG
Article usage
Altmetrics
Vol 7 Issue 1
Table of Contents
Efficacy of indacaterol/glycopyrronium versus salmeterol/fluticasone in current and ex-smokers: a pooled analysis of IGNITE trials
